GlassScriptPhysician profile
James J Carroll
NPI 1467666982
$1,353.22
in general payments reported to CMS, 2019-2025
10 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $234 · 2021: $526 · 2022: $54.90 · 2023: $23.44 · 2024: $149 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $562.80 | 2019-2021 | |
| Alcon Vision LLC | $218.37 | 2020-2025 | Rhopressa, Rocklatan |
| Antares Pharma, INC. | $197.63 | 2020-2021 | |
| Coopervision INC. | $144.25 | 2022-2025 | Onefit Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $109.55 | 2024 | Xiidra, Miebo |
| Genentech USA, INC. | $45.95 | 2019 | |
| Dexcom, INC. | $21.65 | 2021 | |
| Harrow Eye, LLC | $18.46 | 2024 | Vevye |
| Mallinckrodt Hospital Products INC. | $18.21 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.